Cargando…

Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis

OBJECTIVES: GCA patients with large vessel involvement (LV-GCA) experience greater CS requirements and higher relapse rates compared with classical cranial GCA. Despite the distinct disease course, interventions in LV-GCA have yet to be investigated specifically. This study aimed to evaluate the CS-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karabayas, Maira, Dospinescu, Paula, Fluck, Nick, Kidder, Dana, Fordyce, Gillian, Hollick, Rosemary J, De Bari, Cosimo, Basu, Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Concise Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756006/ https://www.ncbi.nlm.nih.gov/pubmed/33381680 http://dx.doi.org/10.1093/rap/rkaa069

Ejemplares similares

Stratified glucocorticoid monotherapy is safe and effective for most cases of giant cell arteritis
por: Karabayas, Maira, et al.
Publicado: (2020)

Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis. Reply
por: Karabayas, Maira
Publicado: (2021)

A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis
por: Philobos, Mariana, et al.
Publicado: (2021)

Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis
por: Mazumder, Rifat, et al.
Publicado: (2021)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

The relationship between glycated haemoglobin levels and the risk of giant cell arteritis – a case–control study
por: Mukhtyar, Chetan, et al.
Publicado: (2020)

Increased number of cases of giant cell arteritis and higher rates of ophthalmic involvement during the era of COVID-19
por: Luther, Rosamond, et al.
Publicado: (2020)

Bone mineral density in patients diagnosed with giant cell arteritis taking glucocorticoids: a case–control study
por: Geressu, Adam, et al.
Publicado: (2023)

Giant Cell Arteritis: A Systematic Review and Meta‐Analysis of Test Accuracy and Benefits and Harms of Common Treatments
Publicado: (2023)

Mimickers of Large Vessel Giant Cell Arteritis
por: Ramon, André, et al.
Publicado: (2022)

Nanocrystalline Silver Dressings in Extensive Pemphigus Vulgaris: An Underutilized Adjunct
por: Sinha, Surabhi, et al.
Publicado: (2021)

Diode Laser as an Adjunctive Treatment for Peri-implant Mucositis: A Systematic Review and Meta-analysis
por: Atieh, Momen A., et al.
Publicado: (2022)

The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2016)

Blood Vessel Resident Human Stem Cells in Health and Disease
por: Craig, David J, et al.
Publicado: (2022)

Large-vessel involvement is predictive of multiple relapses in giant cell arteritis
por: de Mornac, Donatienne, et al.
Publicado: (2021)

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
por: Evans, Jobie, et al.
Publicado: (2016)

Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis
por: Monjo-Henry, Irene, et al.
Publicado: (2023)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Covid-19-vaccine-pfizer-biontech: Large-vessel giant cell arteritis: case report
Publicado: (2022)

Basaloid follicular hamartomas in pediatric Basal Cell Nevus Syndrome: A diagnostic challenge
por: Besagni, Francesca, et al.
Publicado: (2021)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

The efficacy of mycophenolate mofetil in treating Takayasu arteritis: a systematic review and meta-analysis
por: Dai, Danping, et al.
Publicado: (2017)

Large-Vessel Giant Cell Arteritis following COVID-19—What Can HLA Typing Reveal?
por: Stojanovic, Maja, et al.
Publicado: (2023)

Pharmacodynamic analysis of apremilast in Japanese patients with moderate to severe psoriasis: Results from a phase 2b randomized trial
por: Imafuku, Shinichi, et al.
Publicado: (2020)

Hip fracture incidence and mortality in chronic kidney disease: the GLOMMS-II record linkage cohort study
por: Robertson, Lynn, et al.
Publicado: (2018)

Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions
por: Sugihara, Takahiko, et al.
Publicado: (2020)

PET-Derived Increased Inflammation in Large Vessels is linked to Relapse-Free Survival in Patients with Giant Cell Arteritis
por: Fröhlich, Matthias, et al.
Publicado: (2023)

Doppler ultrasound and giant cell arteritis
por: Suelves, Ana Marina, et al.
Publicado: (2010)

An Unusual Presentation of Giant Cell Arteritis
por: Prabhavalkar, Siddhesh, et al.
Publicado: (2012)

Biologic Therapies for Giant Cell Arteritis
por: Harrington, Robert, et al.
Publicado: (2021)

Giant Cell Arteritis and Cardiac Comorbidity
por: Arias, Magela, et al.
Publicado: (2021)

Treatment failure in giant cell arteritis
por: Unizony, Sebastian H, et al.
Publicado: (2021)

Advances in the Treatment of Giant Cell Arteritis
por: Castañeda, Santos, et al.
Publicado: (2022)

Treatment of Giant Cell Arteritis (GCA)
por: Régent, Alexis, et al.
Publicado: (2022)

An Unusual Case of Giant Cell Arteritis
por: Goyal, Nitasha, et al.
Publicado: (2022)

Evolution of ultrasound in giant cell arteritis
por: Kirby, Colm, et al.
Publicado: (2022)

Cardiovascular lesions in giant cell arteritis
por: Dzhus, Marta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_onrqkefcp80a6kas6gpk0polnv